Drug intelligence / Profile preview

GeliO3

Development stage: Preclinical
Lead developer: Bioemmei
Modality: Hydrogel Systems → Drug Delivery Systems
Administration: Topical

Overview

GeliO3 is an ozonized gel used for mucosal reparative treatment in the oral cavity. It has sanitizing and preventive properties for teeth and gums, and serves as an adjuvant treatment after periodontal and implant surgery. The gel demonstrates antimicrobial properties while maintaining safe cytocompatibility toward host tissues. It can also be used to relieve children's gums and is useful against dermatitis and as a hand sanitizer.

Brand names: GeliO3GeliO-3GeliO 3

Beyond the preview

Go deeper on GeliO3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GeliO3.

Explore the full profile